Analysts Are Gushing Over Dominion Energy, Inc. (D), Sage Therapeutics, Inc. (SAGE)

Dominion Energy, Inc. (NYSE:D) last session’s volume of 1.85 million shares was lower than its average volume of 2.11 million shares. The stock, after opening at $80.43, hit $80.35 through the close by scoring -0.04%.

Dominion Energy, Inc. (D) Analyst Opinion

Dominion Energy, Inc. has a consensus hold rating from 16 Wall Street analysts, and the number of shares currently sold short amount to at least 2.09% of shares outstanding. The stock spiked 2.99% last month and is up 4.91 this year. Wall Street is only getting more bullish on the stock, with 4 of analysts who cover D having a buy-equivalent rating. Analysts have placed a $80.46 price target on Dominion Energy, Inc., suggesting a 0.14% gain from recent close. It’s currently trading about -1.59% below its 52-week high.

Dominion Energy, Inc. Earnings Surprise

Dominion Energy, Inc. (D) failed to surprise the stock market in its last reported earnings when it earned $0.67 a piece versus the consensus-estimated $0.67. Its revenue totaled $2.94 billion down -13.16% from the previous quarter.

Dominion Energy, Inc. (NYSE:D) Intraday View

This stock (D) is ahead of its 52-week low with 15.59%. Its last month’s stock price volatility remained 0.98% which for the week stands at 1.1%. The share price has moved forward from its 20 days moving average, trading at a distance of 3.08% and stays 2.55% away from its 50 days moving average. Over the last five days, shares have managed 1.76% gains and now is up 3.77% since hitting its 200-day moving average of $78.21. Dominion Energy, Inc. (D) has made its way to a 12-month gain of 9.89%.

Turning to Sage Therapeutics, Inc. (NASDAQ:SAGE), its shares were trading at $61.67 a gain of $0.31, on the trading floor. The stock, after opening at $61.42, touched a high of $63 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.7. Sage Therapeutics, Inc. has 6 buy ratings, 2 holds and 0 sells even after the stock tumbled -32.08% from its high of $ 90.80 to a $2.29 billion market value through last close.

Sage Therapeutics, Inc. (NASDAQ:SAGE) Intraday Trading

The counter witnessed a trading volume of 0.36 million shares versus an average volume of 0.56 million shares during last trading session. Its last month’s stock price volatility remained 2.7% which for the week approaches 3.26%. The lowest price the stock reached in the last trading day was $61.12 and compares with the $38.30 52-week low. The stock recovered 61.02% since its low point and has performed 20.78% year-to-date.

Previous articleVaried Analyst Comments On Simon Property Group, Inc. (SPG), Corcept Therapeutics Incorporated (CORT)
Next articleStreet Analysts View On Anthem, Inc. (ANTM), Halozyme Therapeutics, Inc. (HALO)